Arkema Stock CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Stocks
AKEp
FR0010313833
Specialty Chemicals
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 15:59:59 | |||
| 59.20 EUR | +1.89% |
|
58.68 | -0.89% |
| 06-08 | Goldman Sachs Downgrades Arkema to Neutral, Lowers PT | MT |
| 06-08 | Arkema retreats following Goldman Sachs downgrade |
| Market Cap | 4.48B 5.2B 4.12B 3.88B 7.29B 490B 7.35B 48.85B 19.02B 241B 19.5B 19.09B 833B | P/E 2026 * |
17.8x | P/E 2027 * | 14.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.92B 8.02B 6.36B 5.99B 11.25B 757B 11.34B 75.36B 29.34B 371B 30.09B 29.45B 1,285B | EV / Sales 2026 * |
0.75x | EV / Sales 2027 * | 0.74x |
| Free-Float |
89.17% | Yield 2026 * |
6.1% | Yield 2027 * | 6.33% |
Last Transcript: Arkema
| 1 week | +3.09% | ||
| Current month | -3.35% | ||
| 1 month | -4.98% | ||
| 3 months | +5.06% | ||
| 6 months | +13.14% | ||
| Current year | +13.96% |
| 1 week | 56.7 | 59.48 | |
| 1 month | 56.7 | 63.3 | |
| 3 years | 48.32 | 104.4 | |
| 5 years | 48.32 | 134.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2006-03-05 | |
| Director of Finance/CFO | 55 | 2018-05-31 | |
Armand Ajdari
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 63 | 2006-03-05 | |
| Director/Board Member | 57 | 2013-12-31 | |
| Director/Board Member | 62 | 2014-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.89% | +0.63% | -1.86% | -29.49% | 5.11B | ||
| -1.76% | +1.75% | +1.10% | +47.80% | 77.08B | ||
| -0.31% | +0.92% | -22.54% | +8.32% | 37.05B | ||
| +0.85% | +6.56% | -24.86% | -37.79% | 32.24B | ||
| -0.06% | -3.62% | +8.73% | +15.41% | 25.18B | ||
| -0.14% | +9.69% | +150.35% | +15.01% | 23.74B | ||
| +0.93% | +1.66% | +17.57% | -0.57% | 20.51B | ||
| +0.27% | +9.01% | +173.23% | -27.00% | 19.59B | ||
| +1.89% | +6.05% | - | - | 13.27B | ||
| +1.70% | +3.13% | -15.12% | -12.27% | 13.16B | ||
| Average | +0.39% | +3.52% | +31.84% | -2.29% | 29.09B | |
| Weighted average by Cap. | -0.20% | +3.46% | +22.80% | +10.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.17B 10.62B 8.43B 7.93B 14.9B 1,003B 15.03B 99.86B 38.88B 492B 39.87B 39.02B 1,702B | 9.42B 10.92B 8.66B 8.15B 15.31B 1,030B 15.44B 103B 39.95B 506B 40.97B 40.1B 1,749B |
| Net income | 252M 292M 231M 218M 409M 27.54B 413M 2.74B 1.07B 13.52B 1.1B 1.07B 46.76B | 321M 372M 295M 278M 522M 35.13B 527M 3.5B 1.36B 17.24B 1.4B 1.37B 59.64B |
| Net Debt | 2.43B 2.82B 2.24B 2.11B 3.96B 266B 3.99B 26.51B 10.32B 131B 10.59B 10.36B 452B | 2.44B 2.83B 2.24B 2.11B 3.97B 267B 4B 26.6B 10.36B 131B 10.62B 10.4B 454B |
Employees
-
Sector
Specialty Chemicals
Calendar
| Date | Price | Change |
|---|---|---|
| 26-06-17 | 59.20 € | +1.89% |
| 26-06-16 | 58.10 € | +0.26% |
| 26-06-15 | 57.95 € | +1.58% |
| 26-06-12 | 57.05 € | -0.95% |
| 26-06-11 | 57.60 € | +0.30% |
- Stock Market
- Stocks
- AKE Stock
- AKEp Stock
Select your edition
All financial news and data tailored to specific country editions



















